The short answer
An added risk from yohimbe with ropinirole has not been established in a direct clinical study. Yohimbe can still cause blood-pressure or heart-rhythm problems, so review the exact product with your prescriber, especially if you have dizziness or fainting.
What this answer covers
Pausinystalia johimbe products used alongside immediate-release oral ropinirole. Studies of measured pharmaceutical yohimbine are indirect for a whole-bark product or an extract with an unknown alkaloid amount.
- Supplement or preparation
- Yohimbe
- Medication ingredient
- ropinirole
Blood-pressure effects need assessment
Ropinirole can cause blood pressure to fall on standing, particularly around dose increases. Yohimbe products have separate safety concerns involving pressure, pulse and anxiety. These facts justify caution, but they do not show that the exact combination invariably raises or lowers blood pressure, or that one ingredient cancels the other.
Yohimbe is not a dependable low-pressure treatment
A small Parkinson-disease trial tested pharmaceutical yohimbine for non-drug-induced orthostatic hypotension and found no significant improvement in ambulatory pressure measures. It was not a trial of ropinirole-associated hypotension or of yohimbe bark. Do not use this supplement to treat faintness without an assessment.
Product amounts vary
An analysis of 49 supplement brands found large differences in yohimbine content and frequent labeling problems. A botanical name on a bottle does not establish the amount studied in a drug trial. Your pharmacist needs the actual product, other ingredients and serving information to assess it.
Review symptoms and planned changes
Discuss starting or stopping the supplement with the treating clinician. Seek prompt assessment for fainting or a new irregular heartbeat rather than adjusting ropinirole yourself. The available evidence does not establish a safe yohimbe dose or a protective number of hours between these products.
Evidence and practical considerations
Side effects & toxicity
An added risk from yohimbe with ropinirole has not been established in a direct clinical study. Yohimbe can still cause blood-pressure or heart-rhythm problems, so review the exact product with your prescriber, especially if you have dizziness or fainting.
- Exact scope
- Pausinystalia johimbe products used alongside immediate-release oral ropinirole. Studies of measured pharmaceutical yohimbine are indirect for a whole-bark product or an extract with an unknown alkaloid amount. with Immediate-release oral ropinirole; hydrochloride tablets expressed as free-base equivalent in the original label.
- Medication form and route
- oral
What remains uncertain
- No quantified exact-pair risk or universal safe dose is established. Product effects and studies in different populations cannot establish the outcome during ropinirole co-use.
Factors that may matter: Exact product composition; Underlying indication and blood-pressure symptoms; Other medicines and planned changes.
Read the supporting source summaries
Source 1: Current U.S. regulatory product labeling
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Adults using immediate-release oral ropinirole tablets for Parkinson disease or restless legs syndrome.
Label warns about sudden sleep episodes, orthostatic hypotension, hallucinations and compulsive behaviors. With prescribed L-dopa, dyskinesia was reported more often with ropinirole than placebo (34% versus 13%) in advanced-Parkinson trials.
How this applies: Exact medication evidence and an explicit hydrochloride/free-base bridge from section 11. Supports specified risks and prescriber supervision; not proof of an untested supplement interaction.
Those trial rates are not Mucuna, yohimbe or synephrine co-use rates. Immediate-release label findings do not establish every formulation or supplement dose.
Source 2: U.S. federal supplement safety guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: People considering yohimbe/yohimbine products; safety reports are not ropinirole-specific.
Guidance describes blood-pressure and heart-rhythm problems, anxiety and serious reported adverse events, with uncertainty about product amounts.
How this applies: Supports review of the exact product and independent safety concerns, not a specific quantified interaction.
Reports do not quantify a ropinirole interaction or prove a whole-bark product equals pharmaceutical yohimbine.
Source 3: Original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Seventeen Parkinson-disease patients with non-drug-induced orthostatic hypotension.
No significant difference in ambulatory blood pressure or heart-rate parameters between baseline, yohimbine and placebo periods.
How this applies: This null result argues against using a yohimbe product as a presumed remedy for ropinirole-associated low blood pressure.
Small trial of yohimbine, not authenticated bark; non-drug-induced hypotension. The abstract does not establish ropinirole exposure.
Source 4: Original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Forty-nine brands labeled as yohimbe/yohimbine from seven U.S. retailers; no clinical participants.
Measured yohimbine ranged from none detected to 12.1 mg per serving. Only 11 brands listed a specific yohimbine quantity, and labeling was often inaccurate.
How this applies: Supports inspecting exact product contents rather than inferring exposure from the botanical name.
Composition survey does not establish a present-day product’s amount, response or interaction incidence.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Initial source-checked research draft. Exact preparation limits and contrary findings documented; clinical review not recorded. | |
| Research summary published |
Article revision: 7ca1a05d02822a60
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.